These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17119701)

  • 1. In vitro minocycline activity on superinfecting microorganisms isolated from chronic periodontitis patients.
    de Oliveira LF; Jorge AO; Dos Santos SS
    Braz Oral Res; 2006; 20(3):202-6. PubMed ID: 17119701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetracycline-resistant micro-organisms recovered from patients with refractory periodontal disease.
    Olsvik B; Hansen BF; Tenover FC; Olsen I
    J Clin Periodontol; 1995 May; 22(5):391-6. PubMed ID: 7601921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification, and susceptibility to seven antimicrobial agents, of 61 gram-negative anaerobic rods from periodontal pockets.
    Abu-Fanas SH; Drucker DB; Hull PS; Reeder JC; Ganguli LA
    J Dent; 1991 Feb; 19(1):46-50. PubMed ID: 1901873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolates.
    Gales AC; Jones RN
    Diagn Microbiol Infect Dis; 2000 Jan; 36(1):19-36. PubMed ID: 10744364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbial flora in the acute phase of periodontitis and the effect of local administration of minocycline.
    Umeda M; Tominaga Y; He T; Yano K; Watanabe H; Ishikawa I
    J Periodontol; 1996 Apr; 67(4):422-7. PubMed ID: 8708969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Subgingival distribution of periodontopathic bacteria in periodontic patients and susceptibility of these bacteria to minocycline-HCl].
    Hagiwara S; Umeda M; Tominaga Y; Takamatsu N; Yoshida N
    Kokubyo Gakkai Zasshi; 1995 Dec; 62(4):495-505. PubMed ID: 8583161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subgingival distribution of periodontopathic bacteria in adult periodontitis and their susceptibility to minocycline-HCl.
    Hagiwara S; Takamatsu N; Tominaga Y; Umeda M
    J Periodontol; 1998 Jan; 69(1):92-9. PubMed ID: 9527568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subgingival occurrence and antimicrobial susceptibility of enteric rods and pseudomonads from Brazilian periodontitis patients.
    Barbosa FC; Mayer MP; Saba-Chujfi E; Cai S
    Oral Microbiol Immunol; 2001 Oct; 16(5):306-10. PubMed ID: 11555308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of resistance to metronidazole and minocycline in vitro.
    Larsen T; Fiehn NE
    J Clin Periodontol; 1997 Apr; 24(4):254-9. PubMed ID: 9144048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of tigecycline, a new glycylcycline, tested against 1,326 clinical bacterial strains isolated from Latin America.
    Gales AC; Jones RN; Andrade SS; Pereira AS; Sader HS
    Braz J Infect Dis; 2005 Oct; 9(5):348-56. PubMed ID: 16410885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antimicrobial sensitivity of enteric rods and pseudomonads from advanced adult periodontitis.
    Slots J; Feik D; Rams TE
    Oral Microbiol Immunol; 1990 Oct; 5(5):298-301. PubMed ID: 2098705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial resistance following subgingival and systemic administration of minocycline.
    Preus HR; Lassen J; Aass AM; Ciancio SG
    J Clin Periodontol; 1995 May; 22(5):380-4. PubMed ID: 7601919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility of moxifloxacin against gram-negative enteric rods from colombian patients with chronic periodontitis.
    Ardila CM; Fernández N; Guzmán IC
    J Periodontol; 2010 Feb; 81(2):292-9. PubMed ID: 20151809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
    Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro antimicrobial activity of GAR-936 tested against antibiotic-resistant gram-positive blood stream infection isolates and strains producing extended-spectrum beta-lactamases.
    Biedenbach DJ; Beach ML; Jones RN
    Diagn Microbiol Infect Dis; 2001 Aug; 40(4):173-7. PubMed ID: 11576790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of tigecycline against 3989 Gram-negative and Gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial (TEST Program; 2004).
    Bouchillon SK; Hoban DJ; Johnson BM; Johnson JL; Hsiung A; Dowzicky MJ;
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):173-9. PubMed ID: 16105561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial activity of Uncaria tomentosa against oral human pathogens.
    Ccahuana-Vasquez RA; Santos SS; Koga-Ito CY; Jorge AO
    Braz Oral Res; 2007; 21(1):46-50. PubMed ID: 17426895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continents.
    Sader HS; Jones RN; Stilwell MG; Dowzicky MJ; Fritsche TR
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):181-6. PubMed ID: 16105562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tigecycline activity tested against 11808 bacterial pathogens recently collected from US medical centers.
    Gales AC; Sader HS; Fritsche TR
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):421-7. PubMed ID: 18068934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro antimicrobial activity of tigecycline, a new glycylcycline compound, in freshly prepared medium and quality control.
    Brown SD; Traczewski MM
    J Clin Microbiol; 2007 Jul; 45(7):2173-9. PubMed ID: 17494717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.